{"id":"NCT04350593","sponsor":"Saint Luke's Health System","briefTitle":"Dapagliflozin in Respiratory Failure in Patients With COVID-19","officialTitle":"An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients With COVID-19","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-04-22","primaryCompletion":"2021-03-31","completion":"2021-06-11","firstPosted":"2020-04-17","resultsPosted":"2022-04-13","lastUpdate":"2022-06-10"},"enrollment":1250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["COVID-19"],"interventions":[{"type":"DRUG","name":"Dapagliflozin 10 milligram (mg)","otherNames":["Farxiga"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dapagliflozin 10mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is an international, multicenter, parallel-group, randomized, double-blind, placebo controlled, study in hospitalized adult patients with coronavirus disease 2019 (COVID-19) in the United States, Brazil, Mexico, Argentina, India, Canada, and United Kingdom. The study is evaluating the effect of dapagliflozin 10 milligrams versus placebo, given once daily for 30 days in addition to background local standard of care therapy, on reducing complications and all-cause mortality, or improving clinical recovery.","primaryOutcome":{"measure":"Prevention of COVID-19 Complications or Death: During the 30-day Treatment Period, Time to First Occurrence of New/Worsened Organ Dysfunction During Index Hospitalization or Death From Any Cause.","timeFrame":"Randomization through Day 30","effectByArm":[{"arm":"Dapagliflozin 10mg","deltaMin":12.4,"sd":null},{"arm":"Placebo","deltaMin":15.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":95,"countries":["United States","Argentina","Brazil","Canada","India","Mexico","United Kingdom"]},"refs":{"pmids":["40739638","38770818","35699910","34302745"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":70,"n":613},"commonTop":["Acute Kidney Injury"]}}